本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immunovant, Inc.

36.65
-1.0100-2.68%
盤後36.60-0.0500-0.14%19:30 EDT
成交量:157.40萬
成交額:5,753.19萬
市值:75.65億
市盈率:-13.01
高:37.50
開:37.43
低:36.19
收:37.66
52周最高:45.42
52周最低:14.58
股本:2.06億
流通股本:8,956.68萬
量比:1.37
換手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-2.8178
每股收益(LYR):-2.7716
淨資產收益率:-80.10%
總資產收益率:-46.73%
市淨率:10.29
市盈率(LYR):-13.22

資料載入中...

2026/09/04

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/06

重要事件披露

Form 8-K - Current report
2025/12/12

重要事件披露

Form 8-K - Current report
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/11

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses